Annual Revenue
$1.02 B
-$53.10 M-4.93%
31 December 2023
Summary:
Emergent BioSolutions annual revenue is currently $1.02 billion, with the most recent change of -$53.10 million (-4.93%) on 31 December 2023. During the last 3 years, it has fallen by -$439.20 million (-30.04%). EBS annual revenue is now -37.60% below its all-time high of $1.64 billion, reached on 31 December 2021.EBS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$283.80 M
+$35.70 M+14.39%
30 September 2024
Summary:
Emergent BioSolutions quarterly revenue is currently $283.80 million, with the most recent change of +$35.70 million (+14.39%) on 30 September 2024. Over the past year, it has increased by +$19.80 million (+7.50%). EBS quarterly revenue is now -55.20% below its all-time high of $633.50 million, reached on 31 December 2021.EBS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.09 B
+$19.80 M+1.84%
30 September 2024
Summary:
Emergent BioSolutions TTM revenue is currently $1.09 billion, with the most recent change of +$19.80 million (+1.84%) on 30 September 2024. Over the past year, it has increased by +$18.00 million (+1.67%). EBS TTM revenue is now -33.26% below its all-time high of $1.64 billion, reached on 31 December 2021.EBS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.9% | +7.5% | +1.7% |
| 3 y3 years | -30.0% | -9.1% | -30.2% |
| 5 y5 years | +45.0% | +2.8% | +22.7% |
EBS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -37.6% | at low | -55.2% | +79.8% | -33.3% | +16.6% |
| 5 y | 5 years | -37.6% | +45.0% | -55.2% | +79.8% | -33.3% | +22.7% |
| alltime | all time | -37.6% | +2157.8% | -55.2% | +1431.3% | -33.3% | +5141.9% |
Emergent BioSolutions Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $283.80 M(+14.4%) | $1.09 B(+1.8%) |
| June 2024 | - | $248.10 M(-15.2%) | $1.07 B(-7.2%) |
| Mar 2024 | - | $292.40 M(+8.3%) | $1.16 B(+13.2%) |
| Dec 2023 | $1.02 B(-4.9%) | $269.90 M(+2.2%) | $1.02 B(-4.9%) |
| Sept 2023 | - | $264.00 M(-20.3%) | $1.08 B(+4.0%) |
| June 2023 | - | $331.30 M(+109.9%) | $1.03 B(+10.2%) |
| Mar 2023 | - | $157.80 M(-51.2%) | $938.80 M(-13.0%) |
| Dec 2022 | $1.08 B(-34.4%) | $323.10 M(+45.2%) | $1.08 B(-22.3%) |
| Sept 2022 | - | $222.50 M(-5.5%) | $1.39 B(-6.1%) |
| June 2022 | - | $235.40 M(-21.0%) | $1.48 B(-8.5%) |
| Mar 2022 | - | $297.90 M(-53.0%) | $1.62 B(-1.5%) |
| Dec 2021 | $1.64 B(+12.1%) | $633.50 M(+103.0%) | $1.64 B(+4.6%) |
| Sept 2021 | - | $312.10 M(-16.1%) | $1.57 B(-2.9%) |
| June 2021 | - | $372.10 M(+15.7%) | $1.61 B(+0.1%) |
| Mar 2021 | - | $321.70 M(-42.7%) | $1.61 B(+10.4%) |
| Dec 2020 | $1.46 B(+48.7%) | $561.90 M(+56.4%) | $1.46 B(+18.3%) |
| Sept 2020 | - | $359.30 M(-3.2%) | $1.24 B(+7.2%) |
| June 2020 | - | $371.10 M(+118.4%) | $1.15 B(+17.2%) |
| Mar 2020 | - | $169.90 M(-49.5%) | $984.50 M(+0.1%) |
| Dec 2019 | $983.50 M(+39.4%) | $336.20 M(+21.7%) | $983.50 M(+10.3%) |
| Sept 2019 | - | $276.20 M(+36.6%) | $891.60 M(+15.7%) |
| June 2019 | - | $202.20 M(+19.7%) | $770.80 M(-0.2%) |
| Mar 2019 | - | $168.90 M(-30.9%) | $772.30 M(+9.5%) |
| Dec 2018 | $705.40 M(+43.8%) | $244.30 M(+57.2%) | $705.30 M(+10.4%) |
| Sept 2018 | - | $155.40 M(-23.7%) | $638.83 M(+3.6%) |
| June 2018 | - | $203.70 M(+99.9%) | $616.63 M(+25.2%) |
| Mar 2018 | - | $101.90 M(-42.7%) | $492.70 M(+0.5%) |
| Dec 2017 | $490.40 M(+42.0%) | $177.82 M(+33.5%) | $490.40 M(+17.7%) |
| Sept 2017 | - | $133.21 M(+67.0%) | $416.74 M(+5.5%) |
| June 2017 | - | $79.77 M(-19.9%) | $394.94 M(+5.7%) |
| Mar 2017 | - | $99.60 M(-4.4%) | $373.66 M(+8.2%) |
| Dec 2016 | $345.40 M(-7.1%) | $104.16 M(-6.5%) | $345.40 M(-8.2%) |
| Sept 2016 | - | $111.41 M(+90.5%) | $376.17 M(-4.4%) |
| June 2016 | - | $58.49 M(-18.0%) | $393.61 M(-7.6%) |
| Mar 2016 | - | $71.34 M(-47.1%) | $426.01 M(+10.6%) |
| Dec 2015 | $371.94 M(+18.9%) | $134.93 M(+4.7%) | $385.20 M(+12.2%) |
| Sept 2015 | - | $128.85 M(+41.8%) | $343.22 M(+11.3%) |
| June 2015 | - | $90.88 M(+197.6%) | $308.26 M(+1.1%) |
| Mar 2015 | - | $30.53 M(-67.2%) | $304.83 M(-2.5%) |
| Dec 2014 | $312.79 M(+21.3%) | $92.95 M(-1.0%) | $312.79 M(+2.4%) |
| Sept 2014 | - | $93.89 M(+7.4%) | $305.51 M(+6.1%) |
| June 2014 | - | $87.46 M(+127.2%) | $287.92 M(+8.2%) |
| Mar 2014 | - | $38.49 M(-55.1%) | $266.06 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $257.92 M(+19.5%) | $85.67 M(+12.3%) | $257.92 M(+4.6%) |
| Sept 2013 | - | $76.30 M(+16.3%) | $246.60 M(+9.9%) |
| June 2013 | - | $65.60 M(+116.1%) | $224.32 M(+5.9%) |
| Mar 2013 | - | $30.36 M(-59.2%) | $211.88 M(-1.9%) |
| Dec 2012 | $215.88 M(+6.7%) | $74.35 M(+37.7%) | $215.88 M(+20.9%) |
| Sept 2012 | - | $54.01 M(+1.6%) | $178.50 M(-2.6%) |
| June 2012 | - | $53.16 M(+54.7%) | $183.25 M(-16.0%) |
| Mar 2012 | - | $34.36 M(-7.1%) | $218.23 M(+7.8%) |
| Dec 2011 | $202.41 M(-19.5%) | $36.97 M(-37.1%) | $202.41 M(-13.5%) |
| Sept 2011 | - | $58.76 M(-33.3%) | $233.89 M(-6.1%) |
| June 2011 | - | $88.14 M(+375.6%) | $249.12 M(+11.7%) |
| Mar 2011 | - | $18.53 M(-72.9%) | $223.11 M(-11.2%) |
| Dec 2010 | $251.38 M(+7.1%) | $68.46 M(-7.5%) | $251.38 M(+6.2%) |
| Sept 2010 | - | $73.99 M(+19.1%) | $236.73 M(+14.9%) |
| June 2010 | - | $62.14 M(+32.8%) | $206.01 M(-5.1%) |
| Mar 2010 | - | $46.80 M(-13.0%) | $217.07 M(-7.5%) |
| Dec 2009 | $234.79 M(+31.5%) | $53.80 M(+24.3%) | $234.79 M(+8.3%) |
| Sept 2009 | - | $43.27 M(-40.9%) | $216.73 M(-5.8%) |
| June 2009 | - | $73.19 M(+13.4%) | $230.06 M(+14.8%) |
| Mar 2009 | - | $64.52 M(+80.5%) | $200.35 M(+12.2%) |
| Dec 2008 | $178.55 M(-2.4%) | $35.75 M(-36.8%) | $178.55 M(-23.2%) |
| Sept 2008 | - | $56.60 M(+30.2%) | $232.44 M(+5.9%) |
| June 2008 | - | $43.48 M(+1.8%) | $219.49 M(+10.2%) |
| Mar 2008 | - | $42.72 M(-52.3%) | $199.19 M(+8.9%) |
| Dec 2007 | $182.91 M(+19.8%) | $89.64 M(+105.4%) | $182.91 M(+1.5%) |
| Sept 2007 | - | $43.64 M(+88.2%) | $180.17 M(+0.8%) |
| June 2007 | - | $23.19 M(-12.3%) | $178.70 M(+0.7%) |
| Mar 2007 | - | $26.45 M(-69.6%) | $177.46 M(+2.6%) |
| Dec 2006 | $152.73 M(+16.9%) | $86.89 M(+106.0%) | $172.96 M(+33.2%) |
| Sept 2006 | - | $42.17 M(+92.2%) | $129.86 M(+11.3%) |
| June 2006 | - | $21.95 M(0.0%) | $116.65 M(-5.7%) |
| Mar 2006 | - | $21.95 M(-49.9%) | $123.67 M(-5.4%) |
| Dec 2005 | $130.69 M(+56.5%) | $43.79 M(+51.2%) | $130.69 M(+21.3%) |
| Sept 2005 | - | $28.97 M(0.0%) | $107.77 M(+8.1%) |
| June 2005 | - | $28.97 M(0.0%) | $99.68 M(+8.8%) |
| Mar 2005 | - | $28.97 M(+38.8%) | $91.59 M(+9.7%) |
| Dec 2004 | $83.49 M(+49.7%) | $20.87 M(-0.0%) | $83.50 M(+33.3%) |
| Sept 2004 | - | $20.87 M(0.0%) | $62.62 M(+50.0%) |
| June 2004 | - | $20.87 M(0.0%) | $41.75 M(+100.0%) |
| Mar 2004 | - | $20.87 M | $20.87 M |
| Dec 2003 | $55.77 M(-29.0%) | - | - |
| Dec 2002 | $78.54 M(+73.3%) | - | - |
| Dec 2001 | $45.31 M | - | - |
FAQ
- What is Emergent BioSolutions annual revenue?
- What is the all time high annual revenue for Emergent BioSolutions?
- What is Emergent BioSolutions annual revenue year-on-year change?
- What is Emergent BioSolutions quarterly revenue?
- What is the all time high quarterly revenue for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly revenue year-on-year change?
- What is Emergent BioSolutions TTM revenue?
- What is the all time high TTM revenue for Emergent BioSolutions?
- What is Emergent BioSolutions TTM revenue year-on-year change?
What is Emergent BioSolutions annual revenue?
The current annual revenue of EBS is $1.02 B
What is the all time high annual revenue for Emergent BioSolutions?
Emergent BioSolutions all-time high annual revenue is $1.64 B
What is Emergent BioSolutions annual revenue year-on-year change?
Over the past year, EBS annual revenue has changed by -$53.10 M (-4.93%)
What is Emergent BioSolutions quarterly revenue?
The current quarterly revenue of EBS is $283.80 M
What is the all time high quarterly revenue for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly revenue is $633.50 M
What is Emergent BioSolutions quarterly revenue year-on-year change?
Over the past year, EBS quarterly revenue has changed by +$19.80 M (+7.50%)
What is Emergent BioSolutions TTM revenue?
The current TTM revenue of EBS is $1.09 B
What is the all time high TTM revenue for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM revenue is $1.64 B
What is Emergent BioSolutions TTM revenue year-on-year change?
Over the past year, EBS TTM revenue has changed by +$18.00 M (+1.67%)